Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin
Open Access
- 18 December 2012
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 27 (6) , 2094-2101
Abstract
Background A previous study of 22 patients undergoing either gastric bypass or duodenal switch showed increased systemic exposure of atorvastatin acid 3–8 weeks after surgery in the majority of patients. This study aimed to investigate the long-term effects on systemic exposure of atorvastatin acid in the same group of patients. Methods An 8-h pharmacokinetic investigation was performed a median of 27 months (range 21–45 months) after surgery. Systemic exposure was measured as the area under the plasma concentration versus the time curve from 0 to 8 h postdose (AUC0–8). Linear mixed models with AUC0–8 as the dependent variable were implemented to assess the effect of time, surgical procedure, and body mass index (BMI) as explanatory variables. Results The study enrolled 20 patients. The systemic exposure of atorvastatin acid changed significantly over time (p = 0.001), albeit there was substantial variation between subjects. The effect of time was attenuated but remained significant after adjustment for surgical procedure and BMI (p = 0.048). The initial AUC0–8 increase seen in the majority of patients 3–8 weeks after surgery was normalized long term, with 7 of the 12 gastric bypass patients and 6 of the 8 duodenal switch patients showing decreased AUC0–8 compared with preoperative values. Conclusions The systemic exposure of atorvastatin showed a significant change over time after bariatric surgery, albeit with large inter- and intraindividual variations. The findings indicate that patients using atorvastatin or drugs with similar pharmacokinetic properties should be monitored closely for both therapeutic effects and adverse events the first years after gastric bypass and duodenal switch. ClinicalTrial NCT00331565.Keywords
This publication has 32 references indexed in Scilit:
- The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake InhibitorsAmerican Journal of Psychiatry, 2012
- Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohortSurgery for Obesity and Related Diseases, 2012
- Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of MetforminDiabetes Care, 2011
- Changes in the mucosa of the Roux‐limb after gastric bypass surgeryHistopathology, 2010
- Predicting metabolic adaptation, body weight change, and energy intake in humansAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switchThe American Journal of Clinical Nutrition, 2009
- Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end‐stage renal disease and transplant patients: a pilot studyClinical Transplantation, 2007
- THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”Drug Metabolism and Disposition, 2006
- Small-Intestinal and Colonic Changes after Biliopancreatic Bypass for Morbid ObesityScandinavian Journal of Gastroenterology, 1986
- Gastrointestinal Adaptation Following Small Bowel Bypass for ObesityAnnals of Surgery, 1977